Intervention Protocol

Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission

  1. Chen Mao1,*,
  2. Ya-Fang Huang1,
  3. Zu-Yao Yang1,
  4. Qian-Ling YE2,
  5. Xin-Yin Wu1,
  6. Xue-Feng Hu1,
  7. Zhi-Min Zhai2,
  8. Jin Ling Tang3

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 12 DEC 2012

DOI: 10.1002/14651858.CD010248


How to Cite

Mao C, Huang YF, Yang ZY, YE QL, Wu XY, Hu XF, Zhai ZM, Tang JL. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD010248. DOI: 10.1002/14651858.CD010248.

Author Information

  1. 1

    The Chinese University of Hong Kong, Division of Epidemiology, School of Public Health and Primary Care, Hong Kong, China

  2. 2

    The Second Hospital of Anhui Medical University, Department of Haematology, Hefei, Anhui, China

  3. 3

    The Chinese University of Hong Kong, School of Public Health and Primary Care, New Territories, Hong Kong, China

*Chen Mao, Division of Epidemiology, School of Public Health and Primary Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China. maochen@cuhk.edu.hk.

Publication History

  1. Publication Status: New
  2. Published Online: 12 DEC 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary objective of this study will be to evaluate the efficacy of interleukin-2 (IL-2) as maintenance therapy in patients with acute myeloid leukaemia (AML) who have achieved first complete remission (CR).